Corrective Chemical Peel
Corrective Chemical Peels, featuring the advanced BioRePeelCl3 protocol, represent a fundamental shift in dermatological resurfacing. Moving beyond superficial, mechanical exfoliation, this intervention utilizes a proprietary biphasic formula to deliver clinical-grade acids—including 35% Trichloroacetic Acid (TCA)—deep into the dermal layers. This targeted chemical approach addresses the physiological source of skin dysfunction by dissolving damaged cellular structures, actively stimulating fibroblast proliferation, and correcting persistent conditions such as melasma, hyperpigmentation, and atrophic scarring. Crucially, the formula's lipophilic phase protects the epidermis and preserves moisture during treatment, allowing for profound structural correction and accelerated cellular turnover without the extensive clinical downtime associated with traditional high-percentage TCA peels.
What Is A Corrective Chemical Peel?
01
High-Potency TCA Efficacy
Trichloroacetic Acid (TCA) is the dermatological gold standard for structural skin correction. By delivering a highly concentrated 35% TCA solution directly to the dermis, this protocol aggressively targets cellular dysfunction, stimulating the robust synthesis of new collagen and elastin networks to permanently improve dermal density.
03
Targeted Pigment Correction
By penetrating the deeper dermal layers, the active acids successfully disrupt melanocyte overactivity and accelerate the shedding of pigmented cells. This makes the treatment a highly effective intervention for complex dyschromia, systematically lifting stubborn melasma, post-inflammatory hyperpigmentation (PIH), and severe UV damage.
05
Universal Phototype Safety
Deep chemical peeling historically carries a high risk of post-inflammatory hyperpigmentation in melanin-rich skin. Because the biphasic delivery system bypasses epidermal thermal trauma, this protocol provides safe, predictable, and highly effective structural remodeling across all skin phototypes on the Fitzpatrick scale.
02
Innovative Biphasic Technology
The clinical breakthrough of BioRePeel lies in its two-phase formula. The hydrophilic phase delivers the potent acids and bioactive compounds deep into the tissue, while the lipophilic phase creates a protective, hydrating barrier on the skin's surface. This dual action prevents oxidation and neutralizes the extreme tissue trauma typically associated with deep chemical peels.
04
Acne & Textural Resolution
The protocol integrates salicylic acid alongside TCA to actively dissolve the lipid bonds holding dead skin cells together. This effectively purges deep follicular congestion, neutralizes active acnegenic bacteria, and mechanically smooths the fibrotic tissue associated with post-acne scarring.
06
Zero Epidermal Shedding & Downtime
The primary advantage of this advanced formulation is the elimination of the extended recovery profile. Patients bypass the week-long periods of severe epidermal shedding and erythema required by older peels. The tissue undergoes progressive, microscopic turnover, allowing patients to immediately resume daily activities without compromising clinical results.